Does USTEKINUMAB Cause Liver function test abnormal? 202 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Liver function test abnormal have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
202
Reports of Liver function test abnormal with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
0
Deaths
26
Hospitalizations
How Dangerous Is Liver function test abnormal From USTEKINUMAB?
Of the 202 reports, 26 (12.9%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Liver function test abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 202 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Liver function test abnormal?
METHOTREXATE (1,416)
ETANERCEPT (1,013)
ADALIMUMAB (879)
INFLIXIMAB (609)
ATORVASTATIN (579)
TOCILIZUMAB (526)
LEFLUNOMIDE (489)
ACETAMINOPHEN (465)
TOFACITINIB (436)
ABATACEPT (431)
Which USTEKINUMAB Alternatives Have Lower Liver function test abnormal Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE